Form 8-K - Current report:
SEC Accession No. 0001567264-25-000081
Filing Date
2025-08-12
Accepted
2025-08-12 16:33:36
Documents
13
Period of Report
2025-08-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K intensity-20250808.htm   iXBRL 8-K 30886
2 EX-3.1 amendmenttotheamendedandre.htm EX-3.1 4697
  Complete submission text file 0001567264-25-000081.txt   165520

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT intensity-20250808.xsd EX-101.SCH 1827
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT intensity-20250808_lab.xml EX-101.LAB 24352
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT intensity-20250808_pre.xml EX-101.PRE 14141
15 EXTRACTED XBRL INSTANCE DOCUMENT intensity-20250808_htm.xml XML 3035
Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41109 | Film No.: 251207289
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)